Crestline Management LP Boosts Holdings in Integer Holdings Co. (NYSE:ITGR)

Crestline Management LP raised its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 392.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,434 shares of the medical equipment provider's stock after purchasing an additional 11,503 shares during the period. Crestline Management LP's holdings in Integer were worth $1,913,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of ITGR. KBC Group NV increased its holdings in Integer by 83.3% in the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock valued at $212,000 after buying an additional 726 shares during the last quarter. Tributary Capital Management LLC raised its stake in Integer by 0.8% during the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock worth $38,103,000 after acquiring an additional 2,289 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Integer by 3.9% in the fourth quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock valued at $24,154,000 after buying an additional 6,905 shares during the last quarter. Laurus Investment Counsel Inc. acquired a new position in Integer in the fourth quarter valued at $5,422,000. Finally, Congress Asset Management Co. boosted its stake in shares of Integer by 2.0% during the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock worth $66,041,000 after buying an additional 9,565 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on ITGR shares. StockNews.com cut Integer from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Raymond James boosted their price objective on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. Finally, Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $145.56.

Integer Price Performance

NYSE ITGR traded up $0.51 during trading hours on Tuesday, reaching $121.21. The company's stock had a trading volume of 164,408 shares, compared to its average volume of 364,062. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The stock has a market cap of $4.23 billion, a PE ratio of 36.07, a PEG ratio of 1.72 and a beta of 1.03. The company's 50-day moving average is $118.39 and its two-hundred day moving average is $129.73. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. During the same period in the prior year, the business earned $1.14 earnings per share. The company's quarterly revenue was up 7.3% on a year-over-year basis. Analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Insider Activity at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.16% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.